Cargando…

Characteristic of Parkinson’s disease with severe COVID-19: a study of 10 cases from Wuhan

Information about Parkinson’s disease (PD) patients with severe COVID-19 is scarce. We aimed to analyze the clinical characteristics, outcomes, and risk factors affecting the prognosis of PD patients with severe COVID-19 infection. Clinical data of severe COVID-19 patients admitted at the Union Hosp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhai, Heng, Lv, Yinzhang, Xu, Yu, Wu, Yi, Zeng, Weiqi, Wang, Tao, Cao, Xuebing, Xu, Yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Vienna 2021
Materias:	Neurology and Preclinical Neurological Studies - Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779096/ https://www.ncbi.nlm.nih.gov/pubmed/33392827 http://dx.doi.org/10.1007/s00702-020-02283-y

Ejemplares similares

Clinical Characteristics, Outcomes, and Risk Factors of Disease Severity in Patients With COVID-19 and With a History of Cerebrovascular Disease in Wuhan, China: A Retrospective Study
por: Li, Mengzhen, et al.
Publicado: (2022)

The Rodent Models of Dyskinesia and Their Behavioral Assessment
por: Peng, Qiwei, et al.
Publicado: (2019)

Hyposmia as a marker of (non-)motor disease severity in Parkinson’s disease
por: Roos, Dareia S., et al.
Publicado: (2019)

Oculometric measures as a tool for assessment of clinical symptoms and severity of Parkinson’s disease
por: Reiner, Johnathan, et al.
Publicado: (2023)

Transcranial Magnetic Stimulation Alleviates Levodopa-Induced Dyskinesia in Parkinson's Disease and the Related Mechanisms: A Mini-Review
por: Wu, Yi, et al.
Publicado: (2021)

Neurological Implications of Non-critically Ill Patients With Coronavirus Disease 2019 in a Fangcang Shelter Hospital in Wuhan, China
por: Yan, Nao, et al.
Publicado: (2020)

Viruses, parkinsonism and Parkinson’s disease: the past, present and future
por: Leta, Valentina, et al.
Publicado: (2022)

The heterogeneity of Parkinson’s disease
por: Wüllner, Ullrich, et al.
Publicado: (2023)

Abnormal cerebellum connectivity patterns related to motor subtypes of Parkinson’s disease
por: Chen, Zhenzhen, et al.
Publicado: (2023)

Glucocerebrosidase mutations and Parkinson disease
por: Vieira, Sophia R. L., et al.
Publicado: (2022)

Life style and Parkinson’s disease
por: Reichmann, Heinz, et al.
Publicado: (2022)

The Association of Olfactory Dysfunction With Depression, Cognition, and Disease Severity in Parkinson's Disease
por: Fang, Ting-Chun, et al.
Publicado: (2021)

Substantia nigra neuromelanin magnetic resonance imaging in patients with different subtypes of Parkinson disease
por: Wang, Lu, et al.
Publicado: (2021)

Treatment of Parkinson’s disease in the advanced stage
por: Ossig, C., et al.
Publicado: (2013)

Small intestine dysfunction in Parkinson’s disease
por: Dutkiewicz, Justyna, et al.
Publicado: (2015)

Neuroprotection in Parkinson’s disease: facts and hopes
por: Salamon, András, et al.
Publicado: (2019)

Sleep and non-motor symptoms in Parkinson’s disease
por: Maass, Antonia, et al.
Publicado: (2013)

Parkinson’s disease between internal medicine and neurology
por: Csoti, Ilona, et al.
Publicado: (2015)

Magnetic resonance imaging for the diagnosis of Parkinson’s disease
por: Heim, Beatrice, et al.
Publicado: (2017)

Implications of dopaminergic medication withdrawal in Parkinson’s disease
por: Koschel, J., et al.
Publicado: (2021)

Disease modification in Parkinsonism: obstacles and ways forward
por: Höllerhage, M., et al.
Publicado: (2022)

Genetic testing for Parkinson’s disease in clinical practice
por: Gasser, Thomas
Publicado: (2023)

The use of wearables for the diagnosis and treatment of Parkinson’s disease
por: Reichmann, Heinz, et al.
Publicado: (2023)

Blood neurofilament light chain in Parkinson’s disease
por: Buhmann, Carsten, et al.
Publicado: (2023)

Parkinson’s disease therapy: what lies ahead?
por: Wolff, Andreas, et al.
Publicado: (2023)

The Association Between Clinical Characteristics and Motor Symptom Laterality in Patients With Parkinson's Disease
por: Zhu, Sha, et al.
Publicado: (2021)

Non-motor symptoms of Parkinson’s disease: the patient’s perspective
por: Breen, Kieran C., et al.
Publicado: (2012)

Flavor perception and the risk of malnutrition in patients with Parkinson’s disease
por: Roos, Dareia S., et al.
Publicado: (2018)

Parkinson’s: a syndrome rather than a disease?
por: Titova, Nataliya, et al.
Publicado: (2016)

Diagnostic accuracy of glabellar tap sign for Parkinson’s disease
por: Nuuttila, Simo, et al.
Publicado: (2021)

The pathobiological basis of depression in Parkinson disease: challenges and outlooks
por: Jellinger, Kurt A.
Publicado: (2022)

Gender differences in non-motor fluctuations in Parkinson’s disease
por: Donzuso, Giulia, et al.
Publicado: (2023)

Current and novel infusion therapies for patients with Parkinson's disease
por: Antonini, Angelo, et al.
Publicado: (2023)

Characteristics of sleep structure in Parkinson's disease patients with hallucinations based on polysomnography
por: Gu, Ruxin, et al.
Publicado: (2022)

Clinical Characteristics and Electrophysiological Biomarkers of Parkinson's Disease Developed From Essential Tremor
por: Wang, Xuemei, et al.
Publicado: (2020)

Diagnostic biomarkers for Parkinson’s disease at a glance: where are we?
por: Cova, Ilaria, et al.
Publicado: (2018)

Classification of advanced stages of Parkinson’s disease: translation into stratified treatments
por: Krüger, Rejko, et al.
Publicado: (2017)

Wilful pathogens provoke a gut feeling in Parkinson’s disease
por: Sian-Hülsmann, Jeswinder
Publicado: (2021)

Fatigue in fluctuating Parkinson’s disease patients: possible impact of safinamide
por: Pauletti, Caterina, et al.
Publicado: (2023)

Motor and nonmotor complications in Parkinson’s disease: an argument for continuous drug delivery?
por: Chaudhuri, K. Ray, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_4u8ica27e0c4fbig5qnkrp7klg